Table 3.
Laboratory values before onset of calcific uremic arteriolopathy adverse event
| Variable | Placebo (n=18) | Cinacalcet (n=6) |
|---|---|---|
| Intact PTH (pg/ml) | 796 (225, 2093) | 410 (71, 4957) |
| Serum calcium (mg/dl) | 9.8 (8.5, 10.6) | 9.7 (8.0, 11.6) |
| Serum phosphorus (mg/dl) | 5.8 (4.5, 8.1) | 6.3 (3.4, 10.2) |
| Alkaline phosphatase (U/L) | 98 (67, 148) | 190 (65, 648) |
| Bone alkaline phosphatase (µg/L) | 15.56 (7.97, 33.62) | 44.01 (15.97, 188.97) |
| N-telopeptide (nmol/L) | 205.2 (36.8, 490.5) | 491.4 (109.9, 1471.4) |
| Hemoglobin (g/dl) | 11.4 (8.3, 13.2) | 11.6 (6.7, 13.1) |
| Albumin (g/dl) | 3.4 (2.7, 3.8) | 3.2 (2.8, 4.1) |
| Total protein (g/dl) | 6.9 (6.4, 7.9) | 6.9 (5.9, 7.3) |
Values are expressed as median (10%, 90% percentile). PTH, parathyroid hormone.